<DOC> 
<DOCNO>1040505_business_story_3207788.utf8</DOCNO> 
<TEXT> 

The Telegraph - Calcutta : Business
 Wednesday, May 05, 2004  Business Briefs																								 Calcutta, May 4: Dena Bank has approached the government seeking permission to dilute Rs 80-crore worth of equity in public via a second issue at a premium to improve its capital adequacy ratio. We are expecting government permission shortly, chairman and managing director A. K. Khandelwal said. The proposed issue will bring down the government stake in the bank to around 51 per cent, he said. The issue was likely to hit the market in the second half of current fiscal, he said.																								 New Delhi, May 4: Sterlite Industries, United Breweries, Bharat Forge and Centurion Bank are planning rights issues totalling Rs 2,450 crore this fiscal compared with Rs 1,006 crore raised in 2003-04. Sterlite is planning a Rs 1,819-crore issue, UB plans to raise Rs 214 crore, while Bharat Forge is to mop up Rs 124 crore.																								 New Delhi, May 4: IDBI-led lenders will meet the Naresh Chandra panel soon to discuss the 2,184-MW Dabhol power projects future course of action, before a final negotiation with overseas lenders on May 12 in London.																								 Mumbai, May 4: The promoters of the National Commodity and Derivatives Exchange (NCDEX)  ICICI Bank, National Stock Exchange, Life Insurance Corporation and Nabard  will divest 5 per cent each to usher in Indian Farmers Fertilizers Cooperative and another investor at a price to be fixed shortly.																								 Mumbai, May 4: Wockhardt Ltd has received approval from the Drug Controller General of India (DCGI) to conduct phase I clinical trials of WCK-1152, its new chemical entity, to treat hospital and community-acquired respiratory tract infections.																								 New Delhi, May 4: Radico Khaitan has reported a 43 per cent rise in net profit at Rs 25.68 crore in 2003-04 compared with Rs 17.9 crore in the previous fiscal.																								 Mumbai, May 4: Elder Pharmaceuticals has completed the allotment for 17.16 lakh global depository receipts of $7.20 aggregating around $12.35 million.
</TEXT> 
</DOC>